Safety, Immunogenicity and Efficacy of R21 Matrix-M in 5-17 Month Old Children in Nanoro, Burkina Faso
Clinical trial NCT03896724 · COMPLETED
Trial details
- NCT number
- NCT03896724
- Sponsor
- University of Oxford
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-05-07
- Primary completion
- 2023-07-07
- Enrollment
- 450
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.